Aurobindo Pharma USA, Inc. is recalling blood pressure medication – WSBT-TV

Aurobindo Pharma USA, Inc. is recalling 80 many of Amlodipine Valsartan Capsules USP, Valsartan HCTZ Capsules, USP and Valsartan Capsules USP attributable to tag portions of an surprising impurity.

It is a voluntary engage for patrons.

Learn the plump engage here:

Aurobindo Pharma USA, Inc. is conducting a voluntary engage of 80 many of Amlodipine Valsartan Capsules USP, Valsartan HCTZ Capsules, USP and Valsartan Capsules USP to the patron stage attributable to the detection of tag portions of an surprising impurity came upon within the carried out drug product. The impurity detected within the carried out drug product is N-nitrosodiethylamine (NDEA), which is a substance that happens naturally in distinct foods, ingesting water, air pollution, and industrial processes, and has been labeled as a probable human carcinogen as per Global Agency for Learn on Cancer (IARC) classification. So a ways, Aurobindo Pharma USA, Inc. has now not got any reports of unfavourable events associated to this engage.

Amlodipine Valsartan Capsules USP, Valsartan HCTZ Capsules, USP and Valsartan Capsules USP are indicated to manipulate excessive blood stress and for the cure of coronary heart failure. Patients who prescribed Amlodipine Valsartan Capsules USP, Valsartan HCTZ Capsules, USP and Valsartan Capsules USP should aloof proceed taking their treatment, as the danger of anguish to the patient’s health will possible be increased if the cure is stopped straight away with none replacement cure. Patients should aloof contact their pharmacist or physician who can expose them about an replacement cure old to returning their treatment.

The merchandise discipline to have interaction are listed below and packaged in bottles. The product is also identified by checking the product title, producer shrimp print and batch or lot quantity on the bottle containing these merchandise.

NDCName and strengthCountLot numberExpiry

65862-737-30Amlodipine and Valsartan Capsules USP5mg/160mg30VESA17013-A10/2019

65862-737-30Amlodipine and Valsartan Capsules USP5mg/160mg30VESA17014-A10/2019

65862-737-30Amlodipine and Valsartan Capsules USP5mg/160mg30VESA18001-A12/2019

65862-737-30Amlodipine and Valsartan Capsules USP5mg/160mg30VESA18002-A12/2019

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA17008-A10/2019

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA17010-A10/2019

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA18002-A01/2020

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA18003-A01/2020

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA18007-A03/2020

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA18008-A03/2020

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA17008-A05/2019

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA17014-A10/2019

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA17015-A10/2019

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA17016-A10/2019

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA17017-A10/2019

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA18002-A01/2020

65862-740-30Amlodipine and Valsartan Capsules USP10mg /320mg30VKSA18004-A01/2020

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17012-A11/2019

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17013-A11/2019

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17014-A11/2019

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17015-A11/2019

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17016-A11/2019

65862-738-30Amlodipine and Valsartan Capsules USP5mg /320mg30VMSA17017-A11/2019

65862-739-30Amlodipine and Valsartan Capsules USP10mg/160mg30VFSA17009-A10/2019

65862-740-30Amlodipine and Valsartan Capsules USP 10mg /320mg30VKSA18005-A03/2020

65862-740-30Amlodipine and Valsartan Capsules USP 10mg /320mg30VKSA18001-A01/2020

65862-550-90Valsartan and Hydrochlorothiazide tablets & USP 320mg/12.5mg90HRSA17033-A10/2020

65862-550-90Valsartan and Hydrochlorothiazide tablets & USP 320mg/12.5mg90HRSA17034-A10/2020

65862-550-90Valsartan and Hydrochlorothiazide tablets & USP 320mg/12.5mg90HRSA17035-A10/2020

65862-550-90Valsartan and Hydrochlorothiazide tablets & USP 320mg/12.5mg90HRSA17036-A10/2020

65862-550-90Valsartan and Hydrochlorothiazide tablets & USP 320mg/12.5mg90HRSA17037-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17033-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17034-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17035-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17036-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17040-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17041-A11/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17042-A11/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP160mg/12.5mg90HTSA17043-A11/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17049-A08/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17054-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17055-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17056-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17057-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17058-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17059-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17060-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17062-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17066-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17067-A11/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17068-A11/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17069-A11/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18001-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18002-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18003-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18004-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18005-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18006-A12/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB18007-A12/2020

65862-547-90Valsartan and Hydrochlorothiazide tablets USP 80mg/12.5mg90HVSA17011-A11/2020

65862-547-90Valsartan and Hydrochlorothiazide tablets USP 80mg/12.5mg90HVSA17012-A11/2020

65862-547-90Valsartan and Hydrochlorothiazide tablets USP 80mg/12.5mg90HVSA18001-A12/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17023-A08/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17036-A11/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17037-A11/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17038-A11/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17039-A11/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB17040-B11/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB18001-A12/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB18002-A12/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB18003-A12/2020

65862-549-90Valsartan and Hydrochlorothiazide tablets USP 160mg/25mg90HVSB18004-A12/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP 160mg/12.5mg90HTSA17037-A10/2020

65862-548-90Valsartan and Hydrochlorothiazide Capsules USP 160mg/12.5mg90HTSA17039-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17063-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17064-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP 320mg/25mg90HTSB17065-A10/2020

65862-551-90Valsartan and Hydrochlorothiazide Capsules USP & 320/25mg90HTSB18029-A03/2021

65862-573-90Valsartan Capsules USP 320mg90VUSD17008-A07/2019

65862-573-90Valsartan Capsules USP 320mg90VUSD17009-A09/2019

Amlodipine Valsartan Capsules USP, Valsartan HCTZ Capsules, USP and Valsartan Capsules USP were distributed nationwide to Aurobindo Pharma USA, Inc. wholesale, distributor, repackager and retail potentialities. Aurobindo Pharma USA, Inc. is notifying its distributors and potentialities by phone and in writing to straight away dwell distribution of the true plenty being recalled and to insist their sub-accounts. Aurobindo Pharma USA, Inc. is arranging for return of all recalled merchandise to Inmar/CLS Medturn. Directions for returning recalled merchandise are given within the engage letter.

Consumers with clinical questions regarding this engage or to memoir an unfavourable tournament can contact Aurobindo Pharma USA, Inc. at:

1-866-850-2876 Possibility 2

pvg@aurobindousa.com

Consumers should aloof additionally contact their physician or healthcare supplier if they’ve skilled any concerns that would possibly per chance per chance be associated to taking or the use of this drug product.

Any fashioned questions regarding the return of this product please contact InmarCLS-Medturn at 1-877-208-2407 or email rxrecalls@inmar.com (are living calls got 9 am -5:00 pm Eastern Time).

Harmful reactions or quality concerns associated with the use of this product will possible be reported to FDA’s MedWatch Harmful Occasion Reporting program both by phone, on line, by fashioned mail or by fax.

Full and put up the memoir On-line: www.fda.gov/medwatch/memoir.htm

Traditional Mail or Fax: Secure construct www.fda.gov/MedWatch/getforms.htm or name 1-800-332-1088 to expect a reporting construct, then whole and return to the tackle on the pre-addressed construct, or put up by fax to 1-800-FDA-0178.

This engage is being performed with the records of the U.S. Meals and Drug Administration.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *